Dusty Crevice

Buy monitor later in day (@woot amazing deal ty) 4am pc transaction declines 6 am monitor completes. Thankful 4 much but getting declined after hours to prevent is extremely disappointing/frustrating. Bank says no authorization attempt. Amazon Pay says not us. @woot please help

Get ad for woot. Customer since 2020, love. Load app. Notice 22% bday coupon. Find perfect PC for me, never thought'd be possible @woot is so great! Buy, order placed and "processing" Wake up this morning to declined order. Made every effort to preempt. No real explanation.

@Gerko21 @tmo_melonmaster @Pirat_Nation Tard alert.

@tmo_melonmaster @Pirat_Nation It's never coming out. The entire business model is reliant on the whales continuing to fund it with the promise that it will be good "when it releases"

Star Citizen is free to play until May 27, as developer Cloud Imperium Games gives players temporary access to the game during its latest event. The game is approaching $1 billion in player funding. That would make it one of the most funded video game projects ever. Star Citizen has been in development for more than 10 years and still has no full release date. The single-player mode, Squadron 42, is currently expected to launch in 2026.

@NHL @Ticketmaster Drury tying with 8 seconds and Finnyginny GW in oooovvvveeeerrrrtimeee.

Time to reminisce... 😌 What is the most memorable #StanleyCup Playoffs moment to you? Presented by @Ticketmaster

@NFL_DovKleiman The house that Josh built.

𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴: The Bills' new stadium is almost done ahead of its scheduled opening for the 2026 NFL season. • $2.1 billion cost • 1.35 million square feet • 60,000-seat capacity • Real heated grass One of the nicest stadiums we have ever seen.

@kingtutcap Excellent bagcalling.

$ASTI: Finally got a hold of the full interview. - "Right now, we’ve got multiple deals and partnerships with various companies that all work together to help us achieve our larger goals. We announced that we were partnering with a company that does its manufacturing in space. They’re going to launch in four or five months. - "We also signed a deal with a lasering company, which will help with lasering power, increasing the power grid in space. That could be advantageous for DoD or AI or other things." - "We fit a lot of buckets in manufactured readiness. Golden Dome is clearly going to be a massive use of power also. They’re going to use a lot of power. We’re aiming to meet these power needs as the space market continues to expand." - "We’ve had meetings with several DOW departments, including terrestrial ones. There’s a big push everywhere to have their suppliers manufactured ready, but it’s also keeping your surveillance and everything. They want something that is ready for use and is going to stay in the air. For example, a blimp at 65,000 to 80,000 feet that’ll stay in the air for a while." - "You have attack drones and you have surveillance drones. Attack drones, 2% of them come back. They don’t care as much about attack drones. Surveillance drones, they would want to loiter. They want them to be able to loiter for a long time. So, our product would work well there. They also want products that work well in water. Our product works probably the best in water. Silicon is not going to work in the water; it’s just not as efficient and experiences other functionality issues. So, we’re a good product for water applications." - "In the U.S., our primary markets would be space, DoD, and commercial. We do some work in Europe and India too. For terrestrial solar, we occasionally will bid on something that’s kind of a very, very weird, specialized project. But we’re really looking at doing DoD related work for surveillance typically."

@kingtutcap You're talking about the same company that is down 99.99% from highs and whose losses exceeded 7m last year, right?

@DMRussini @jeffzrebiec At least Kraft let Belicheck do the whole song and dance before he started telling people he fired him. If I were Harbaugh I would want to take over Cleveland after a move like this.

@Biotenic @Biotech_8899 Is there something specific about the situation that leads you to believe that VEN+AZA should be performing at such a high degree in CR2? At the R&D conference in late Oct the company framed the expected REGAL patient by referencing acsjournals.onlinelibrary.wiley.com/doi/full/10.10….

@Biotech_8899 I expect it’s going to be much higher. I think that’s much more likely than this being a highly efficacious drug

$SLS The Christmas gifts keep on rolling in ir.sellaslifesciences.com/news/News-Deta…

@anthonystaj @DiarmuidEgan4 It not only showed SIGNIFICANT benefit, the benefit increased with fewer lines of previous therapy and showed very impressive ORR considering the patient population. Frontline trial upcoming.

@DiarmuidEgan4 No, sorry. 009 showed no benefit

@anthonystaj @DiarmuidEgan4 This is such a ridiculous statement.

@CMGoodwin79 @alexbrasky ???????????

@alexbrasky Doesn’t matter, the defense isn’t stopping the Chiefs, they needed to score on every possession, no stop, the game is over and this team is in all sorts of trouble, just not enough talent

Keon Coleman involved early in this one.. but it’s a catch for 6 yards 😑

@RowdySal @PFF Like the 31 yard fourth down play of the year?

@PFF Every Bills fans favorite words: “Since 2020” (because they want to remove the years he was horrible.) “Total TDs” because they love to add his inflated tush push TDs)

Patrick Mahomes and Josh Allen meet again on Sunday 😈

@TT_stocks_ @MartinShkreli I literally filed an SEC complaint against you last year pump and pump shithead TT 😭😭😭 The fucking irony.

Here maybe I need to refresh your memory a little bit. 7 years in prison can really mess with you mentally I’m sure. You raised the price of a life saving drug by over 4,000% .. that’s how you screwed everyone over along with investors. @MartinShkreli little twerp

@MSollender @Biotenic I dont want to be too picky but there is a difference between events and a discontinuation. Of note, discontinuations are noted as treatment completion. If these are GPS patients, GPS administration takes a year to complete, which would be significantly better than historical BAT

The reddit page for this company does not disappoint, so thank you for that I guess

@biowaor @barstoolsports Lol I'm a Bills fan and hate Patricia more than anyone other than Brady but he wasn't trying to run out of bounds, same way Allen wasn't fake sliding vs the Steelers. Both Allen and Patricia get away with plenty, too, but this specific play is ridiculous. His eyes are up field.

@barstoolsports I've seen this over a dozen times. Is the wrong clip posted?

If you liked the Kenny Pickett fake slide you’ll love the Pat Mahomes fake step out

@Dallasvlla9901 @Bernard22190947 What about Point72? Surely Point72 was aware of a 14:1 RS coming a month later and still bought in. Their board is extensive, former VP and officer of labeling at MRK and multiple other board members also on double digit billion dollar companies. Surely these ppl want to make $

I find $vcnx an intriguing lotto ticket. In July will release results for their drug pepinemab in Alzhiemers. Why? They learned a lot in failed huntingtons trial.

@CEOofstocks @MrZackMorris I just feel like $50 is a little low even with a good amount more dilution. Best case scenario this thing is 25-30B+ market cap tho. Would be awhile for that and require their drugs to continue to nail trials across multiple cancers but it's not off the table.

@CEOofstocks @MrZackMorris If they utilize the shelf they will be doing it for commercialization and at that point will reject a buyout proposal that doesn't blow them away.

I’ve been out of the small cap game for a bit because I trade SPY full time. I know you guys love Pennies and they are fun as f to swing together. What are some of the ones you guys are watching with upcoming catalysts?

@CEOofstocks @MrZackMorris MC 6B is 107 dollars at current float, how does a $50 PT make sense????

@MrZackMorris $SLS. $57M MC bio - P3 results imminent as per CEO - TAM is massive - First AML CR2 indication treatment possibly in 40 years - Significantly derisked By the end of April, the IDMC will reveal the trial results which point to a home run. MC will be $6-$8B, buyout for $50/shr